Treatment strategies for postviral olfactory dysfunction: A systematic review
- PMID: 35317886
- PMCID: PMC8984764
- DOI: 10.2500/aap.2022.43.210107
Treatment strategies for postviral olfactory dysfunction: A systematic review
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has been associated with a dramatic increase in postviral olfactory dysfunction (PVOD) among patients who are infected. A contemporary evidence-based review of current treatment options for PVOD is both timely and relevant to improve patient care. Objective: This review seeks to impact patient care by qualitatively reviewing available evidence in support of medical and procedural treatment options for PVOD. Systematic evaluation of data quality and of the level of evidence was completed to generate current treatment recommendations. Methods: A systematic review was conducted to identify primary studies that evaluated treatment outcomes for PVOD. A number of medical literature data bases were queried from January 1998 to May 2020, with completion of subsequent reference searches of retrieved articles to identify all relevant studies. Validated tools for the assessment of bias among both interventional and observational studies were used to complete quality assessment. The summary level of evidence and associated outcomes were used to generate treatment recommendations. Results: Twenty-two publications were identified for qualitative review. Outcomes of alpha-lipoic acid, intranasal and systemic corticosteroids, minocycline, zinc sulfate, vitamin A, sodium citrate, caroverine, intranasal insulin, theophylline, and Gingko biloba are reported. In addition, outcomes of traditional Chinese acupuncture and olfactory training are reviewed. Conclusion: Several medical and procedural treatments may expedite the return of olfactory function after PVOD. Current evidence supports olfactory training as a first-line intervention. Additional study is required to define specific treatment recommendations and expected outcomes for PVOD in the setting of COVID-19.
Figures
Similar articles
-
Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations.Int Forum Allergy Rhinol. 2020 Sep;10(9):1065-1086. doi: 10.1002/alr.22624. Epub 2020 Jun 25. Int Forum Allergy Rhinol. 2020. PMID: 32567798 Free PMC article.
-
Olfactory Training for Postviral Olfactory Dysfunction: Systematic Review and Meta-analysis.Otolaryngol Head Neck Surg. 2021 Feb;164(2):244-254. doi: 10.1177/0194599820943550. Epub 2020 Jul 14. Otolaryngol Head Neck Surg. 2021. PMID: 32660334
-
Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study.Ann Otol Rhinol Laryngol. 2023 Jun;132(6):709-714. doi: 10.1177/00034894221111245. Epub 2022 Jul 13. Ann Otol Rhinol Laryngol. 2023. PMID: 35833237 Clinical Trial.
-
Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD?World J Otorhinolaryngol Head Neck Surg. 2020 Nov;6(Suppl 1):S26-S32. doi: 10.1016/j.wjorl.2020.05.004. Epub 2020 May 19. World J Otorhinolaryngol Head Neck Surg. 2020. PMID: 32837756 Free PMC article. Review.
-
Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review.Front Neurosci. 2021 Aug 12;15:708510. doi: 10.3389/fnins.2021.708510. eCollection 2021. Front Neurosci. 2021. PMID: 34456675 Free PMC article.
Cited by
-
Olfactory immune response to SARS-CoV-2.Cell Mol Immunol. 2024 Feb;21(2):134-143. doi: 10.1038/s41423-023-01119-5. Epub 2023 Dec 25. Cell Mol Immunol. 2024. PMID: 38143247 Free PMC article. Review.
-
Post-traumatic olfactory dysfunction: a scoping review of assessment and rehabilitation approaches.Front Neurol. 2023 Jul 13;14:1193406. doi: 10.3389/fneur.2023.1193406. eCollection 2023. Front Neurol. 2023. PMID: 37521284 Free PMC article.
-
Integrating the patient's voice into the research agenda for treatment of chemosensory disorders.Chem Senses. 2024 Jan 1;49:bjae020. doi: 10.1093/chemse/bjae020. Chem Senses. 2024. PMID: 38761171 Free PMC article.
-
Vitamin A and Its Related Diseases.Food Sci Nutr. 2025 Jul 15;13(7):e70630. doi: 10.1002/fsn3.70630. eCollection 2025 Jul. Food Sci Nutr. 2025. PMID: 40672537 Free PMC article. Review.
-
Delivery of Topical Drugs to the Olfactory Cleft.J Clin Med. 2023 Nov 29;12(23):7387. doi: 10.3390/jcm12237387. J Clin Med. 2023. PMID: 38068438 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical